2005-2015年美国中枢脑肿瘤登记处老年人群非恶性与恶性脑膜瘤发病率及生存分析
基于美国中枢脑肿瘤登记处(CBTRUS)2005-2015年数据,分析65岁以上人群非恶性与恶性脑膜瘤的发病率和生存。非恶性脑膜瘤发病率随年龄增长而升高,女性和黑人群体更高;恶性脑膜瘤发病率无性别差异。非恶性脑膜瘤生存随年龄增长、黑人和男性更差,手术切除联合放疗较单纯切除未改善生存。
要点
- 非恶性脑膜瘤发病率在65-69岁至85岁以上人群翻倍,女性所有年龄组均高于男性。
- 恶性脑膜瘤发病率在任何年龄组均无性别差异,黑人群体的非恶性和恶性脑膜瘤发病率均显著更高。
- 非恶性脑膜瘤中,手术切除联合放疗较单纯切除未改善生存。
核心结论
- 研究报告老年人群非恶性脑膜瘤发病率增加,黑人和女性发病率更高;恶性脑膜瘤发病率无性别差异;黑人和男性死亡风险更高;非恶性脑膜瘤切除联合放疗未带来生存优势;识别出需进一步研究的临床相关差异。
研究设计与样本
- 基于美国中枢脑肿瘤登记处(CBTRUS)2005-2015年数据的分析,纳入65岁以上非恶性和恶性脑膜瘤患者,按年龄、性别、种族、族裔、部位和治疗方式分析年龄调整发病率(每10万人年),并对CBTRUS数据子集使用Kaplan-Meier和多变量Cox比例风险模型分析生存。
主要发现
- 非恶性脑膜瘤发病率从65-69岁至85岁以上翻倍,女性所有年龄组均显著高于男性。
- 恶性脑膜瘤发病率在任何年龄组均无性别差异。
- 非恶性和恶性脑膜瘤发病率在黑人群体均显著高于其他群体。
- 非恶性脑膜瘤生存随年龄增长、黑人和男性更差,按5岁年龄组分析亦然。
- 非恶性脑膜瘤中手术切除联合放疗较单纯切除未改善生存。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Meningioma incidence increases significantly with age. In the expanding elderly population, we lack complete understanding of population-based trends in meningioma incidence/survival. We provide an updated, comprehensive analysis of meningioma incidence and survival for individuals aged over 65. METHODS: Data were obtained from the Central Brain Tumor Registry of the United States (CBTRUS) from 2005-2015 for nonmalignant and malignant meningioma. Age-adjusted incidence rates per 100000 person-years were analyzed by age, sex, race, ethnicity, location, and treatment modalities. Survival was analyzed using Kaplan-Meier and multivariable Cox proportional hazards models for a subset of CBTRUS data. RESULTS: Nonmalignant meningioma incidence doubled from adults age 65-69 years to adults over age 85 years and was significantly greater in females than males for all ages. Malignant meningioma incidence did not differ by sex for any age grouping. Nonmalignant and malignant meningioma incidence was significantly greater in black populations versus others. Nonmalignant meningioma survival was worse with age, in black populations, and in males, including when analyzed by 5-year age groups. Surgical resection and radiation did not improve survival compared with resection alone in nonmalignant meningioma. CONCLUSIONS: This study reports increasing nonmalignant meningioma incidence in the elderly, increased incidence in black populations, and in females. In contrast, malignant meningioma incidence did not differ between sexes. Risk of death was higher for black individuals and males. Additionally, radiation did not confer a survival advantage when combined with resection for nonmalignant meningioma. Thus, we identify clinically relevant discrepancies in meningioma incidence/survival that require further study.
引用
- Achey RL, Gittleman H, Schroer J, et al. Nonmalignant and malignant meningioma incidence and survival in the elderly, 2005-2015, using the Central Brain Tumor Registry of the United States. Neuro Oncol. 2019. PMID: 30295804. doi:10.1093/neuonc/noy162
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。